Menu
Peptide Database
Results
No peptides found
Featured

Use search to browse all 100+ peptides

Gonadorelin

GnRH, Luteinizing Hormone-Releasing Hormone, LHRH, Factrel

Quick Stats
Studies 192
Trials 100
2025 pubmed

Can bladder endometriosis be hard to diagnose? A two-case report and literature review.

Li. Xingchen X; Li. Hong H

Key Findings

  • Bladder endometriosis is rare and often diagnosed late
  • Pelvic MRI is effective for pre‑operative diagnosis
  • Post‑surgical hormone therapy with GnRH agonists and dienogest showed short‑term success

Practical Outcomes

  • For most biohackers, the findings have little direct relevance. The main takeaway is that this research is about a specific gynecological condition, not a general health‑optimizing protocol involving gonadorelin.

Summary

The study describes two rare cases of bladder endometriosis, showing that MRI can help diagnose it and that surgery followed by hormone therapy (GnRH agonists and dienogest) prevented short‑term recurrence. This information is specific to a niche medical condition and does not provide actionable guidance for health‑optimizing practices like longevity or performance enhancement.

Abstract

Bladder endometriosis (BE) is an uncommon form of deep infiltrating endometriosis (DIE). This report aims to present two cases of BE with markedly contrasting clinical histories and presentations to highlight diagnostic challenges and discuss management strategies. We describe the clinical presentation, diagnostic workup including pelvic magnetic resonance imaging (MRI), surgical management (laparoscopic partial cystectomy), histopathological findings, and short-term follow-up of two young women diagnosed with BE. Relevant literature is reviewed to contextualize the findings. Both patients were accurately diagnosed preoperatively via MRI and underwent successful laparoscopic partial cystectomy, with histopathology confirming BE. Postoperative management involved a sequential protocol of gonadotropin-releasing hormone agonists (GnRH-a) followed by dienogest, which resulted in favorable short-term results, with no recurrence noted during follow-up. Diagnosing BE is often straightforward when typical clinical and imaging findings align. However, diagnostic delays are common due to the condition's rarity and symptom overlap. Early diagnosis is crucial for achieving better outcomes. For women of reproductive age experiencing recurrent pelvic symptoms, even atypical ones, early pelvic imaging examinations are recommended. MRI plays a key role in diagnosing BE, guiding treatment decisions, and assisting with differential diagnosis. Enhancing awareness of BE among clinicians and radiologists is essential to expedite diagnosis and treatment.

Study Information

Provider

pubmed

Year

2025

Date

2025-09-04T00:00:00.000Z

DOI

10.3389/fmed.2025.1607689

References

26